Drug Type TCR-T Cell therapy |
Synonyms GB30103 |
Target |
Action inhibitors |
Mechanism KRAS G13D inhibitors(KRAS G13D inhibitors), Gene transference(Gene transference), T lymphocyte replacements |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | China | 13 Feb 2023 |